165 related articles for article (PubMed ID: 8650225)
1. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia.
Schafer M; Mousa SA; Zhang Q; Carter L; Stein C
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6096-100. PubMed ID: 8650225
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
Schäfer M; Carter L; Stein C
Proc Natl Acad Sci U S A; 1994 May; 91(10):4219-23. PubMed ID: 7910403
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor and interleukin-1beta are involved in the electroacupuncture-induced analgesic effect on inflammatory pain elicited by carrageenan.
Sekido R; Ishimaru K; Sakita M
Am J Chin Med; 2004; 32(2):269-79. PubMed ID: 15315264
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor in antinociception and inflammation.
Schäfer M; Mousa SA; Stein C
Eur J Pharmacol; 1997 Mar; 323(1):1-10. PubMed ID: 9105870
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: involvement of areas coexpressing CRF receptors and opioid peptides.
Mousa SA; Bopaiah CP; Richter JF; Yamdeu RS; Schäfer M
Neuropsychopharmacology; 2007 Dec; 32(12):2530-42. PubMed ID: 17375137
[TBL] [Abstract][Full Text] [Related]
6. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells.
Brack A; Rittner HL; Machelska H; Leder K; Mousa SA; Schäfer M; Stein C
Pain; 2004 Dec; 112(3):229-238. PubMed ID: 15561377
[TBL] [Abstract][Full Text] [Related]
7. Immune-derived opioids and peripheral antinociception.
Cabot PJ
Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):230-2. PubMed ID: 11236131
[TBL] [Abstract][Full Text] [Related]
8. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation.
Mousa SA; Schäfer M; Mitchell WM; Hassan AH; Stein C
Eur J Pharmacol; 1996 Sep; 311(2-3):221-31. PubMed ID: 8891603
[TBL] [Abstract][Full Text] [Related]
9. Morphological correlates of immune-mediated peripheral opioid analgesia.
Mousa SA
Adv Exp Med Biol; 2003; 521():77-87. PubMed ID: 12617566
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin.
Stein C; Gramsch C; Herz A
J Neurosci; 1990 Apr; 10(4):1292-8. PubMed ID: 2158530
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and peripheral analgesia.
Schäfer M
Adv Exp Med Biol; 2003; 521():40-50. PubMed ID: 12617563
[TBL] [Abstract][Full Text] [Related]
12. Involvement of corticotropin-releasing factor in the antinociception produced by interleukin-1 in mice.
Kita A; Imano K; Nakamura H
Eur J Pharmacol; 1993 Jun; 237(2-3):317-22. PubMed ID: 8365458
[TBL] [Abstract][Full Text] [Related]
13. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
Song ZH; Takemori AE
J Pharmacol Exp Ther; 1990 Aug; 254(2):363-8. PubMed ID: 2166788
[TBL] [Abstract][Full Text] [Related]
14. The peripheral corticotropin-releasing factor (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: involving CRF, opioid and glucocorticoid receptors.
Yarushkina NI; Filaretova LP
Inflammopharmacology; 2018 Apr; 26(2):305-318. PubMed ID: 29404882
[TBL] [Abstract][Full Text] [Related]
15. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release.
Karanth S; Lyson K; Aguila MC; McCann SM
Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567
[TBL] [Abstract][Full Text] [Related]
16. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.
Brack A; Rittner HL; Machelska H; Shaqura M; Mousa SA; Labuz D; Zöllner C; Schäfer M; Stein C
Pain; 2004 Mar; 108(1-2):67-75. PubMed ID: 15109509
[TBL] [Abstract][Full Text] [Related]
17. Antinociception by neutrophil-derived opioid peptides in noninflamed tissue--role of hypertonicity and the perineurium.
Rittner HL; Hackel D; Yamdeu RS; Mousa SA; Stein C; Schäfer M; Brack A
Brain Behav Immun; 2009 May; 23(4):548-57. PubMed ID: 19233260
[TBL] [Abstract][Full Text] [Related]
18. Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas.
Mousa SA; Khalefa BI; Shaqura M; Al-Madol M; Treskatsch S; Schäfer M
J Neuroinflammation; 2022 Jun; 19(1):148. PubMed ID: 35705992
[TBL] [Abstract][Full Text] [Related]
19. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
20. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
